What is the management for Ovarian Hyperstimulation Syndrome (OHSS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Management of Ovarian Hyperstimulation Syndrome (OHSS) should focus on supportive care and prevention of complications, with treatment varying based on severity, as outlined in the most recent guidelines 1.

Overview of OHSS Management

The management of OHSS involves a step-wise approach based on the severity of the syndrome. For mild cases, outpatient management is often sufficient, while more severe cases require hospitalization and more intensive interventions.

Treatment Based on Severity

  • Mild OHSS: Outpatient management with oral hydration (2-3 liters daily), analgesics like acetaminophen for pain, and daily weight monitoring.
  • Moderate OHSS: May require antiemetics such as ondansetron 4-8mg every 8 hours for nausea, and careful monitoring of fluid balance.
  • Severe OHSS: Necessitates hospitalization for IV fluid administration (typically crystalloids), thromboprophylaxis with low molecular weight heparin (enoxaparin 40mg daily), and paracentesis for significant ascites causing respiratory distress or severe abdominal pain.

Key Considerations

  • Intravascular Volume Expansion: Albumin infusion (25g IV) may be considered for intravascular volume expansion in cases with significant third-spacing of fluids.
  • Monitoring: Regular monitoring of electrolytes, renal function, hematocrit, and coagulation parameters is essential, as OHSS can lead to hemoconcentration, electrolyte imbalances, and increased thrombotic risk.
  • Prevention Strategies: Using GnRH antagonist protocols, coasting (withholding gonadotropins), and using GnRH agonist triggers instead of hCG in high-risk patients can help prevent OHSS during fertility treatments, as supported by recent studies 2, 3.

Recent Evidence and Recommendations

The most recent study 1 highlights the importance of early recognition and management of OHSS to prevent complications. It also underscores the role of supportive care and the potential for conservative management in selected cases. Guidelines from previous years 4, 5 provide a foundation for understanding the pathophysiology and management of OHSS, but the approach should always be tailored to the individual patient's risk factors and severity of symptoms.

References

Research

Ovarian Hyperstimulation: Diagnosis, Prevention, and Management.

Seminars in reproductive medicine, 2021

Research

The prevention of ovarian hyperstimulation syndrome.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2014

Research

The diagnosis and management of ovarian hyperstimulation syndrome.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2011

Research

Treatment of ovarian hyperstimulation syndrome.

Seminars in reproductive medicine, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.